AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENT Sample Clauses

AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENT. THIS AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENT (this “Agreement”) is made and entered into as of the 16th day of August, 2016 (the “Effective Date”) by and between Akriveia Therapeutics Inc., a for-profit company with a registered address at 000 Xxxxx XxXxxx Xxxxxxx, Xxxxx, XX 00000 (“Licensee”) and City of Hope, a California nonprofit public benefit corporation located at 0000 Xxxx Xxxxxx Xxxx, Duarte, California 91010 (“City of Hope” or “COH”). Licensee and COH are each sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
AutoNDA by SimpleDocs
AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENT. This Amendment No. 3 to the Amended and Restated Exclusive License Agreement is entered into by and among Xxxx Xxxxxxxxxxx, Ph.D. and Xxxxx Xxxxxxx, M.D. (the “Licensors”), Pear Tree Pharmaceuticals, Inc., a corporation duly organized and existing under the laws of the State of Delaware (the “Licensee”) and Xxxxxxxxxx Xxxxxxxx (“Xxxxxxxx”), effective as of February 13, 2017 (“Amendment No. 3 Effective Date”).
AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENT. Shareholder has entered into an Amended and Restated Exclusive License Agreement (the "Exclusive License") with Teknofanghi [Inc.] in connection with the Draimad product line which is, in form and substance, satisfactory to Purchaser.
AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENT. This Amended and Restated Exclusive License Agreement (the "Agreement") is effective on the date of the last signature below ("Restatement Effective Date"), and is by and between Memorial Sloan Kettering Cancer Center, a New York not-for-profit corporation with principal offices at 0000 Xxxx Xxxxxx, Xxx Xxxx, XX 00000 (hereinafter referred to as "MSK"), and Fate Therapeutics, Inc., a Delaware corporation with principal offices located at 0000 Xxxxxxx Xxxxxxx Xxxxx, Xxxxx 000, Xxx Xxxxx, XX 00000 ("LICENSEE"). MSK and LICENSEE are sometimes referred to singly as “Party” and collectively as “Parties”. TABLE OF CONTENTS PREAMBLE ARTICLES: 1 DEFINITIONS 2 GRANT 3 SUBLICENSES 4 DUE DILIGENCE 5 PAYMENTS 6 REPORTS AND RECORDS 7 PATENT PROSECUTION 8 ENFORCEMENT OF PATENT RIGHTS 9 CONFIDENTIALITY 10 INDEMNIFICATION AND PRODUCT LIABILITY 11 REPRESENTATIONS AND WARRANTIES 12 EXPORT CONTROLS 13 NON-USE OF NAMES 14 ASSIGNMENTS 15 PUBLICATION 16 TERMINATION 17 NOTICES AND OTHER COMMUNICATIONS 18 MISCELLANEOUS PROVISIONS Exhibit A LICENSED RIGHTS – PATENT RIGHTS AND KNOW-HOW

Related to AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENT

  • License Agreement The Trust shall have the non-exclusive right to use the name "Invesco" to designate any current or future series of shares only so long as Invesco Advisers, Inc. serves as investment manager or adviser to the Trust with respect to such series of shares.

  • Development Agreement That certain Development Agreement dated of even date herewith by and between the Company and Developer providing for the development of the Project on the Property, a copy of which is attached hereto as Exhibit C and incorporated herein by reference. Development Fee. As described in Section 6.8.

  • Exclusive License Licensor hereby grants to Licensee and Licensee hereby accepts from Licensor, upon the terms and conditions herein specified, a sole and exclusive license under the Licensed Patent Rights in the Territory, and in the Field of Use to develop, make, have made, import, have imported, use, offer to sell, sell and otherwise commercialize Licensed Product(s).

  • Termination of License Agreement Without limiting the generality of the foregoing, in the event that the License Agreement is terminated in accordance with its terms, this Agreement, including without limitation any Purchase Order(s) or Project Work Orders then-in-effect, shall automatically terminate in its entirety as of the effective date of termination of the License Agreement.

  • Xxxxxx Agreement Xxxx Agreement contains the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior agreement, written or oral, with respect thereto.

  • Non-Exclusive Agreement The services of the Adviser to the Fund under this Agreement are not to be deemed exclusive, and the Adviser shall be free to render similar services or other services to others so long as its services hereunder are not impaired thereby.

  • Non-Exclusive License NCPS grants Company a revocable, non-exclusive, non-transferable and non-sublicensable license during the Term to view-only access the PPEX ATS through the PPEX Site and its related software and other applications and technology for the sole purpose of viewing information about Company and Company Securities and Trades of Company Securities. This license is in addition to the license Company has and is required to maintain during the Term (as defined below) with NCPS’s affiliate, North Capital Investment Technology, Inc., for TransactAPI pursuant to a separate Software and Services License Agreement (“SSLA”). The technology covered by the licenses outlined in this Section 2 is collectively referred to herein as the “Technology”.

  • Collaboration Agreement The Collaboration Agreement shall not have been terminated in accordance with its terms and shall be in full force and effect.

  • PATENT LICENSE AGREEMENT EXCLUSIVE PHS and Licensee agree as follows:

  • Software License Agreement McDATA agrees that all Licensed Software will be distributed to Customers subject to a Software License Agreement (including warranty statement), along with a McDATA Manual, in a manner which is (a) no less protective of BROCADE's Intellectual Property Rights in the Licensed Software than the form attached hereto as Exhibit D, and (b) legally enforceable in the jurisdictions in which the Licensed Software, as incorporated into the McDATA Products, is distributed.

Time is Money Join Law Insider Premium to draft better contracts faster.